GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

The use of GLP-1-agonists was associated with a significantly reduced risk of hospitalisation due to alcohol use disorder. Semaglutide was associated with a 36% lower risk, and liraglutide with a ...

Introduction: Atrial fibrillation (AF) in patients with heart failure (HF) is associated with increased morbidity and mortality. Glucagon-like peptide-1 (GLP-1) agonists have been shown to reduce ...

GLP-1 agonist medications have gained significant ... prescribed for diabetes management or weight loss. Here is a list of commonly prescribed GLP-1 medications: GLP-1 medications offer a range ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Continuing GLP-1 receptor agonist medications when undergoing an endoscopic procedure appeared safe in a meta-analysis.

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Opens in a new tab or window PHILADELPHIA -- Chest x-rays did not support the existence of an aspiration risk for surgical candidates using GLP-1 receptor agonists, according to a retrospective study.

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.